How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Salem, Ore.-based Agility Robotics, whose two-legged Digit robots have been tested inside Amazon warehouses, is set to become the first publicly traded U.S. company dedicated solely to humanoid robots ...
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Entrepreneurial family office and growth equity firm Greater Sum Ventures (GSV) today announced its majority investment in SOMA Global, a trailblazer in cloud-native ...
AI success depends on whether enterprise data is ready, reachable, and close enough to the workloads that need it. In this eSpeaks episode, Dell Technologies’ Vrashank Jain explains why fragmented ...
Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...
Jun 30, 2026, 11:17 PM IST IST Go Digit General Ins - Announcement under Regulation 30 (LODR)-Credit Rating May 14, 2026, 05:45 AM IST IST Go Digit General Ins - Announcement under Regulation 30 (LODR ...
Jul 08, 2026, 1:41 AM IST Digitide Solutions - Appointment of Company Secretary and Compliance Officer Jul 08, 2026, 1:32 AM IST Digitide Solutions - Announcement under Regulation 30 ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results